Satu Tommola

1.4k total citations · 1 hit paper
15 papers, 1.1k citations indexed

About

Satu Tommola is a scholar working on Surgery, Oncology and Otorhinolaryngology. According to data from OpenAlex, Satu Tommola has authored 15 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 8 papers in Oncology and 4 papers in Otorhinolaryngology. Recurrent topics in Satu Tommola's work include Ear and Head Tumors (5 papers), Salivary Gland Tumors Diagnosis and Treatment (5 papers) and Oral and Maxillofacial Pathology (3 papers). Satu Tommola is often cited by papers focused on Ear and Head Tumors (5 papers), Salivary Gland Tumors Diagnosis and Treatment (5 papers) and Oral and Maxillofacial Pathology (3 papers). Satu Tommola collaborates with scholars based in Finland, United States and Saudi Arabia. Satu Tommola's co-authors include Ylermi Soini, Heikki Helin, Minna Tanner, Anita I. Kapanen, Heikki Joensuu, Jarmo Salo, Teemu T. Junttila, Eero Sihvo, Jorma Isola and Maija Hollmén and has published in prestigious journals such as Annals of Oncology, Human Pathology and Cancers.

In The Last Decade

Satu Tommola

15 papers receiving 1.1k citations

Hit Papers

Amplification of HER-2 in... 2005 2026 2012 2019 2005 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Satu Tommola Finland 9 659 436 357 281 264 15 1.1k
Eiichi Sasaki Japan 17 438 0.7× 372 0.9× 248 0.7× 44 0.2× 242 0.9× 71 898
Cristina P. Rodriguez United States 13 482 0.7× 196 0.4× 423 1.2× 185 0.7× 217 0.8× 47 818
Janine Soares Portugal 23 458 0.7× 155 0.4× 576 1.6× 23 0.1× 282 1.1× 49 1.2k
Nora Sahnane Italy 20 708 1.1× 244 0.6× 208 0.6× 25 0.1× 318 1.2× 58 1.2k
Adel K. El-Naggar United States 11 296 0.4× 229 0.5× 228 0.6× 297 1.1× 180 0.7× 13 792
P. Scheunemann Germany 13 486 0.7× 299 0.7× 265 0.7× 24 0.1× 266 1.0× 22 864
Volkert B. Wreesmann United States 22 424 0.6× 131 0.3× 413 1.2× 357 1.3× 440 1.7× 32 1.4k
Panteleimon Kountourakis Greece 14 376 0.6× 141 0.3× 97 0.3× 103 0.4× 219 0.8× 32 627
Yong Bao China 16 316 0.5× 318 0.7× 223 0.6× 178 0.6× 245 0.9× 60 780
Anna Calzolari Italy 15 354 0.5× 149 0.3× 206 0.6× 56 0.2× 243 0.9× 31 813

Countries citing papers authored by Satu Tommola

Since Specialization
Citations

This map shows the geographic impact of Satu Tommola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satu Tommola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satu Tommola more than expected).

Fields of papers citing papers by Satu Tommola

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satu Tommola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satu Tommola. The network helps show where Satu Tommola may publish in the future.

Co-authorship network of co-authors of Satu Tommola

This figure shows the co-authorship network connecting the top 25 collaborators of Satu Tommola. A scholar is included among the top collaborators of Satu Tommola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satu Tommola. Satu Tommola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
2.
Wiles, Austin, Matthew Gabrielson, Zubair Baloch, et al.. (2022). Secretory carcinoma of the salivary gland, a rare entity: An international multi‐institutional study. Cancer Cytopathology. 130(9). 684–694. 19 indexed citations
3.
Seppälä, M., Markus Rautiainen, Heini Huhtala, et al.. (2020). The expression and prognostic relevance of programmed cell death protein 1 in tongue squamous cell carcinoma. Apmis. 128(12). 626–636. 3 indexed citations
4.
Tommola, Satu, et al.. (2020). FNA diagnostics of secondary malignancies in the salivary gland: Bi‐institutional experience of 36 cases. Diagnostic Cytopathology. 49(2). 241–251. 6 indexed citations
6.
7.
Almangush, Alhadi, Jaana Hagström, Pasi Hirvikoski, et al.. (2018). Tumor-infiltrating lymphocytes associate with outcome in nonendemic nasopharyngeal carcinoma: a multicenter study. Human Pathology. 81. 211–219. 29 indexed citations
8.
Seppälä, M., Risto Renkonen, Heini Huhtala, et al.. (2016). The expression of cancerous inhibitor protein phosphatase 2A in chronic rhinosinusitis with nasal polyps. Acta Oto-Laryngologica. 136(11). 1173–1179. 7 indexed citations
9.
Vaittinen, Samuli, Petri Koivunen, Jussi Laranne, et al.. (2016). Tumoral Expression of CD 44 and HIF 1α Predict Stage I Oral Cavity Squamous Cell Carcinoma Outcome. Laryngoscope Investigative Otolaryngology. 1(1). 6–12. 4 indexed citations
10.
Almangush, Alhadi, Ricardo D. Coletta, Ibrahim O. Bello, et al.. (2014). A simple novel prognostic model for early stage oral tongue cancer. International Journal of Oral and Maxillofacial Surgery. 44(2). 143–150. 97 indexed citations
11.
Almangush, Alhadi, Ibrahim O. Bello, Harri Keski–Säntti, et al.. (2013). Depth of invasion, tumor budding, and worst pattern of invasion: Prognostic indicators in early‐stage oral tongue cancer. Head & Neck. 36(6). 811–818. 243 indexed citations
12.
Tolonen, Teemu, et al.. (2007). Bax and Bcl-2 are focally overexpressed in the normal epithelium of cancerous prostates. Scandinavian Journal of Urology and Nephrology. 41(2). 85–90. 7 indexed citations
13.
Tanner, Minna, Maija Hollmén, Teemu T. Junttila, et al.. (2005). Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIα gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab. Annals of Oncology. 16(2). 273–278. 545 indexed citations breakdown →
14.
Soini, Ylermi, Satu Tommola, Heikki Helin, & Pekka Martikainen. (2005). Claudins 1, 3, 4 and 5 in gastric carcinoma, loss of claudin expression associates with the diffuse subtype. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 448(1). 52–58. 80 indexed citations
15.
Ikonen, Tarja, Mika Matikainen, Nina Mononen, et al.. (2001). Association of E-cadherin germ-line alterations with prostate cancer.. PubMed. 7(11). 3465–71. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026